secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0001193125-23-210679
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma raises ~$30.9M gross in underwritten public offering; Series 2 warrants exercise price reset to $1.93
--------------------------------------------------------------------------------

- Offering included 875,949 common shares, 15.1M pre-funded warrants, 16.0M common warrants; net proceeds ~$28.3M.
- Combined purchase price $1.93 per share/warrant unit; common warrants exercisable at $3.86 for 5 years.
- Exercise price of 29.8M outstanding Series 2 warrants automatically reset from $11.22 to $1.93 due to offering.
- Proceeds to support clinical development of BB-301 (Phase 1b/2a natural history and treatment studies) and other programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523210679/0001193125-23-210679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312523210679/d518652d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-210679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer